Intellia Therapeutics Inc (NTLA) — Capital Reinvestment Ratio
Intellia Therapeutics Inc (NTLA) has a Capital Reinvestment Ratio of 0.02x as of June 2020, meaning it reinvests 0% of its operating cash flow ($57.42 Million) in capital expenditures ($1.04 Million). See NTLA equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Intellia Therapeutics Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Intellia Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Intellia Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Intellia Therapeutics Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Intellia Therapeutics Inc from 2016 to 2016. For live market cap and broader valuation context, see Intellia Therapeutics Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $36.11 Million | $6.17 Million | — |